BIONEERCORPORATION Logo

BIONEERCORPORATION

Provides molecular biology tools & diagnostic kits for research and clinical applications.

064550 | KO

Overview

Corporate Details

ISIN(s):
KR7064550007
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 71 (주)바이오니아 글로벌센터, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1992, Bioneer Corporation is a biotechnology company specializing in molecular biology products and technologies. The company develops, manufactures, and supplies a comprehensive portfolio for the life sciences and molecular diagnostics (MDx) markets. Its core offerings include proprietary MDx systems and diagnostic kits for various infectious diseases, such as SARS-CoV-2, HIV, HBV, and HCV. Bioneer also provides a wide array of molecular biology reagents, gene synthesis services, PCR systems, and recombinant proteins. A key area of innovation is in laboratory instrumentation, including its patented AccuLoader™ precision device for automated sample handling. The company serves research, clinical, and industrial customers, providing a platform for disease prevention, diagnosis, and treatment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-31 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-06-18 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-06-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-06-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-04-30 00:00
Regulatory Filings
소속부변경
Korean 3.6 KB
2025-04-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.0 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 21.3 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 26.2 KB
2025-03-21 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 644.0 KB
2025-03-20 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 123.8 KB
2025-03-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all BIONEERCORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIONEERCORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIONEERCORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Quratis Inc. Logo
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea
348080
Rani Therapeutics Holdings, Inc. Logo
Develops a capsule to convert injectable biologics into oral pills for chronic diseases.
United States of America
RANI
Raphas Co., Ltd. Logo
Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.
South Korea
214260
Rapport Therapeutics, Inc. Logo
Developing precision small molecule medicines for Central Nervous System (CNS) disorders.
United States of America
RAPP
RAPT Therapeutics, Inc. Logo
Developing immune-targeting therapies for inflammatory and immunologic diseases.
United States of America
RAPT
Recordati Industria Chimica e Farmaceutica Logo
Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.
Italy
REC
RedHill Biopharma Ltd. Logo
Develops oral drugs for GI, infectious diseases, and pandemic preparedness.
United States of America
RDHL
Regencell Bioscience Holdings Ltd Logo
Develops TCM-based therapies for neurocognitive disorders like ADHD and ASD.
United States of America
RGC
REGENERON PHARMACEUTICALS, INC. Logo
A biotech firm inventing, developing, and commercializing medicines for serious diseases.
United States of America
REGN
REGENXBIO Inc. Logo
Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.
United States of America
RGNX

Talk to a Data Expert

Have a question? We'll get back to you promptly.